StonvexLoading…
StonvexStonvexStonvexCore line items from DFH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.32B | $4.45B | $3.75B | $3.34B |
Operating Income | $284.10M | $437.85M | $404.43M | $356.16M |
Net Income | $217.20M | $335.34M | $295.90M | $262.31M |
EPS (Diluted) | $2.14 | $3.34 | $2.79 | $2.45 |
Total Assets | $3.73B | $3.33B | $2.56B | $2.37B |
Total Liabilities | $2.12B | $1.91B | $1.48B | $1.57B |
Cash & Equivalents | $234.77M | $274.38M | $494.14M | $364.53M |
Free Cash Flow OCF − CapEx | $-126.37M | $-281.99M | $369.45M | $-33.17M |
Shares Outstanding | 101.30M | 100.30M | 106.03M | 106.69M |